---
run_id: halo-evidence-vs-diagnosis-validation-v12-criteria-prompted-no-sources-08
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v12
benchmark_version: halo-evidence-vs-diagnosis-validation-v12-v1
model_condition: criteria_prompted_no_sources
run_number: 8
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 2048
seed: 806
prompt_source: condition packet (criteria_prompted_no_sources) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
source_packet: an abstract evidence-quality criteria reminder, then the frozen Advisor prompt; no source names, source cards, or case-specific answer hint - see run-packet.md
source_packet_sha256: eedcb93e6e1ac3648b936a1b5b4926243f86d4779861ecb7569972e407df3b14
condition_packet_sha256: eedcb93e6e1ac3648b936a1b5b4926243f86d4779861ecb7569972e407df3b14
output_file: model-outputs/criteria_prompted_no_sources-08.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - criteria_prompted_no_sources (run 08)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v12-v1`, condition `criteria_prompted_no_sources`, run 8 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 806, on the frozen condition packet.

## Output

**Recommendation:** Run the Demand Cleanroom.

**Reasoning:** The current growth narrative is heavily contaminated by temporary pricing bundles and forward-looking roadmap promises rather than the realized value of the tool. Expansion bookings are likely a result of financial incentives (the bundle) and sales psychology (the roadmap pitch) rather than product utility. This is supported by the fact that regional administrators are already planning to remove the feature, and front-line analysts abandon the tool once the initial rollout phase ends.

The other options fail to isolate the primary risk: whether anyone would pay for this without a discount or a promise of future versions. The Adoption Quality Sprint relies on usage metrics that are already skewed by managers rerunning old samples for training. The Case Evidence Review analyzes accounts that have already renewed, meaning the evidence is biased toward those who found some value or were swayed by the bundle. Only the Demand Cleanroom separates the product's actual market pull from the sales team's promotional tactics.

**Strongest Reason Against:** This intervention intentionally suppresses short-term revenue and risks slowing the current momentum in national accounts. By removing bundle pricing and roadmap pitches, you may see an immediate dip in expansion bookings or longer sales cycles during the test period, which could be perceived by the executive team as a failure of the product rather than a discovery of the truth.

**Observable Evidence to Change Recommendation:** If data emerges showing that the regional administrators removing PlanPilot are doing so for reasons unrelated to product utility (e.g., budget cuts, procurement mandates, or a shift in internal company structure), the risk shifts from "lack of value" to "implementation friction." In that case, I would switch to the Case Evidence Review to identify exactly where the workflow breaks down for analysts.
